EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Use of von Willebrand Factor in VA-ECMO‒Associated Acquired von Willebrand Syndrome: A Nationwide Retrospective Study

Lennart Wild, Thomas Jasny, Jan Andreas Kloka, Konrad Peukert, Matthias Schneider, Christian Putensen, Kai Zacharowski, Benjamin Friedrichson, Florian Piekarski, Christian Bode

Journal of Cardiothoracic and Vascular Anesthesia · 2026-10

DOI: 10.1053/j.jvca.2026.10.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cardiothoracic and Vascular Anesthesia, 2026-10. Verfasst von Lennart Wild und 9 weiteren Autor:innen. Beteiligte Einrichtung: University of Bonn, University Hospital Bonn, Department of Anesthesiology and Intensive Care Medicine, Bonn, Germany. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is a life-saving therapy for refractory cardiocirculatory failure but carries a high bleeding risk, partly due to acquired von Willebrand syndrome (aVWS). With limited evidence-based treatments, von Willebrand factor (VWF) is often used off-label. This study examines nationwide use of VWF in VA-ECMO patients with aVWS in Germany and compares bleeding, thromboembolic events, and survival between treated and untreated patients. DESIGN: Retrospective cohort study based on reimbursement data (2019-2023). SETTING: Multi-institutional analysis of adult VA-ECMO cases treated in German hospitals. PARTICIPANTS: 530 adult patients supported with VA-ECMO and diagnosed with aVWS. INTERVENTIONS: Administration of any dose of VWF during VA-ECMO support versus no VWF treatment. MEASUREMENTS AND MAIN RESULTS: Of 530 patients, 389 (73%) received VWF across 35 of 71 centers contributing patients. Intracranial hemorrhage occurred less frequently in the VWF group (8% v 15%, p = 0.0238). However, haemothorax (37% v 20%, p = 0.0028) was more common with VWF. Thromboembolic events did not differ between groups. ICU LOS was shorter in VWF-treated patients (14 v 18 days, p = 0.0168). The 90-day survival was numerically higher in the VWF group but did not reach statistical significance (p = 0.188). CONCLUSION: In this cohort of VA-ECMO patients with aVWS, VWF was frequently used and associated with lower ICH rates and shorter intensive care unit length of stay, there was no evidence of increased thromboembolic events, but higher rates of other bleeding complications. Prospective randomized trials are warranted to clarify the impact of VWF on clinical outcomes.

Schlagwörter

Stichwörter der Autor:innen

ECMOacquired von Willebrand syndromebleedingintracranial hemorrhagevon Willebrand factor

Autor:innen und Institutionen

  • University of Bonn, University Hospital Bonn, Department of Anesthesiology and Intensive Care Medicine, Bonn, Germany.
  • Goethe University, Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Frankfurt, Germany.
  • University of Bonn, University Hospital Bonn, Department of Neurosurgery, Bonn, Germany.
  • University of Bonn, University Hospital Bonn, Department of Anesthesiology and Intensive Care Medicine, Bonn, Germany. Electronic address: christian.bode@ukbonn.de.

Zitieren

APA

Wild, L., Jasny, T., Kloka, J. A., Peukert, K., Schneider, M., Putensen, C., Zacharowski, K., Friedrichson, B., Piekarski, F., & Bode, C. (2026). Use of von Willebrand Factor in VA-ECMO‒Associated Acquired von Willebrand Syndrome: A Nationwide Retrospective Study. Journal of Cardiothoracic and Vascular Anesthesia. https://doi.org/10.1053/j.jvca.2026.10.005

Vancouver

Wild L, Jasny T, Kloka JA, Peukert K, Schneider M, Putensen C, et al. Use of von Willebrand Factor in VA-ECMO‒Associated Acquired von Willebrand Syndrome: A Nationwide Retrospective Study. Journal of Cardiothoracic and Vascular Anesthesia. 2026. doi:10.1053/j.jvca.2026.10.005

BibTeX
@article{Wild2026,
  author = {Wild, Lennart and Jasny, Thomas and Kloka, Jan Andreas and Peukert, Konrad and Schneider, Matthias and Putensen, Christian and Zacharowski, Kai and Friedrichson, Benjamin and Piekarski, Florian and Bode, Christian},
  title = {Use of von Willebrand Factor in VA-ECMO‒Associated Acquired von Willebrand Syndrome: A Nationwide Retrospective Study},
  journal = {Journal of Cardiothoracic and Vascular Anesthesia},
  year = {2026},
  doi = {10.1053/j.jvca.2026.10.005}
}
Kostenlos starten →